Trials / Recruiting
RecruitingNCT06506565
Low-Dose Ketamine Infusion During Burn Wound Care
A Randomized, Placebo-Controlled, Double-Blind Evaluation of Low-Dose Ketamine Infusion During Burn Wound Care Procedures to Improve Pain Intensity and Reduce Opioid Consumption
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- University of Tennessee · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | Infusion during wound care |
| DRUG | 0.9% NaCl | Infusion during wound care |
Timeline
- Start date
- 2024-07-08
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-07-17
- Last updated
- 2024-12-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06506565. Inclusion in this directory is not an endorsement.